<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>40(7)</volume><submitter>Korn S</submitter><funding>Amgen, Thousand Oaks, CA</funding><funding>AstraZeneca, Wilmington, DE</funding><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Randomized controlled trials (RCTs) of biologics in patients with severe, uncontrolled asthma have shown differential results by baseline blood eosinophil count (BEC). In the absence of head-to-head trials, we describe the effects of biologics on annualized asthma exacerbation rate (AAER) by baseline BEC in placebo-controlled RCTs. Exacerbations associated with hospitalization or an emergency room visit, pre-bronchodilator forced expiratory volume in 1 s, Asthma Control Questionnaire score, and Asthma Quality of Life Questionnaire score were also summarized.&lt;h4>Methods&lt;/h4>MEDLINE (via PubMed) was searched for RCTs of biologics in patients with severe, uncontrolled asthma and with AAER reduction as a primary or secondary endpoint. AAER ratios and change from baseline i</pubmed_abstract><journal>Advances in therapy</journal><pagination>2944-2964</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10272272</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review.</pubmed_title><pmcid>PMC10272272</pmcid><pubmed_authors>Simpson LJ</pubmed_authors><pubmed_authors>Ambrose CS</pubmed_authors><pubmed_authors>Llanos JP</pubmed_authors><pubmed_authors>Korn S</pubmed_authors><pubmed_authors>Cook B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review.</name><description>&lt;h4>Introduction&lt;/h4>Randomized controlled trials (RCTs) of biologics in patients with severe, uncontrolled asthma have shown differential results by baseline blood eosinophil count (BEC). In the absence of head-to-head trials, we describe the effects of biologics on annualized asthma exacerbation rate (AAER) by baseline BEC in placebo-controlled RCTs. Exacerbations associated with hospitalization or an emergency room visit, pre-bronchodilator forced expiratory volume in 1 s, Asthma Control Questionnaire score, and Asthma Quality of Life Questionnaire score were also summarized.&lt;h4>Methods&lt;/h4>MEDLINE (via PubMed) was searched for RCTs of biologics in patients with severe, uncontrolled asthma and with AAER reduction as a primary or secondary endpoint. AAER ratios and change from baseline i</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jul</publication><modification>2026-07-14T19:19:32.168Z</modification><creation>2025-02-19T00:50:03.4Z</creation></dates><accession>S-EPMC10272272</accession><cross_references><pubmed>37233876</pubmed><doi>10.1007/s12325-023-02514-0</doi></cross_references></HashMap>